Gongwin Biopharm Holdings Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced operating loss was TWD 65.241 million compared to TWD 49.346 million a year ago. Net loss was TWD 58.458 million compared to TWD 37.931 million a year ago. Basic loss per share was TWD 0.53 compared to TWD 0.37 a year ago.